Evidence map›Paper›PMID 28420432›Full record

ArticleJournal of experimental & clinical cancer research : CR2017

Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.

Chenbo Ding, Junmin Luo, Xiaobo Fan, Longmei Li, Shanshan Li, Kunming Wen, Jihong Feng, Guoqiu Wu

Abstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Unraveling the role of cancer-associated fibroblasts in colorectal cancer.World journal of gastrointestinal oncology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Molecular Targets and Mechanisms ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  14. Article
  15. CirculatingJournal of clinical medicine · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenbo DingMedical School of Southeast University, Nanjing, 210009, People's Republic of China.
Junmin LuoDepartment of Immunology, Zunyi Medical College, Zunyi, 563003, People's Republic of China. luojm128@163.com.
Xiaobo FanMedical School of Southeast University, Nanjing, 210009, People's Republic of China.
Longmei LiDepartment of Immunology, Zunyi Medical College, Zunyi, 563003, People's Republic of China.
Shanshan LiDepartment of Immunology, Zunyi Medical College, Zunyi, 563003, People's Republic of China.
Kunming WenDepartment of Gastrointestinal Surgery, the Affiliated Hospital of Zunyi Medical College, Zunyi, 563003, People's Republic of China.
Jihong FengDepartment of Oncology, the Affiliated Hospital of Zunyi Medical College, Zunyi, 563003, People's Republic of China. jh_f@163.com.
Guoqiu WuMedical School of Southeast University, Nanjing, 210009, People's Republic of China. Kevin2cbd985@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGrb2-associated binder 2 (Gab2) is a scaffolding protein that serves as a critical signaling amplifier downstream of tyrosine kinase receptors. Our previous study has shown that Gab2 induces epithelial-to-mesenchymal transition (EMT) and promotes metastasis in colorectal cancer (CRC). However, the role of Gab2 in CRC growth and angiogenesis remains unclear.

methodsThe expression of vascular endothelial growth factor (VEGF) in different colorectal tissues was detected by immunohistochemistry and qRT-PCR to evaluate its correlation with Gab2. Lentiviral vectors bearing Gab2 gene and its small interfering RNAs were constructed and transfected into CRC cell lines. The effects of Gab2 on the cell proliferation in vitro and tumorigenesis in vivo, were examined via CCK‑8 assay, colony formation assay as well as tumorigenicity assay respectively. Moreover, to assess its potential role in tumor growth and angiogenesis, the expression of Ki67, CD34 and vascular endothelial growth factor receptor-2 (VEGFR2) were detected by immunohistochemistry in CRC cells tumors. Finally, we evaluated the impact of Gab2 on the expression of c-Myc and VEGF, and the probable effect of mechanistic targeted extracellular signal-regulated kinase (ERK) pathway in suppressing tumor growth and angiogenesis.

resultsUp-regulation of Gab2 expression was found to be positively correlated with VEGF in CRC tissues. Exogenous expression of Gab2 obviously promoted, whereas silencing of Gab2 inhibited, proliferation and clone formation of human CRC cells in vitro. Of note, Gab2 enhanced tumorigenesis and tumor growth in mouse xenografts with high Ki67 expression, and led to an increased vessel density with strong CD34 and VEGFR2 activity. In addition, elevated Gab2 expression obviously up-regulated the expression of VEGF, and stimulated the activation of its downstream genes, ERK1/2 and c-Myc in CRC cells. Instead, down-regulated Gab2 expression significantly reduced the levels of VEGF, and inhibited the transduction of ERK/c-Myc pathway. Finally, we revealed that mechanistic target of mitogen-activated protein kinase (MEK) could attenuate Gab2-induced tumor growth and angiogenesis via altering VEGF and c-Myc levels.

conclusionsThe results from our study suggest that Gab2 promotes intestinal tumor growth and angiogenesis through upregulation of VEGF expression mediated by the MEK/ERK/c-Myc pathway.

Indexed as

Up-RegulationAdaptor Proteins, Signal TransducingAnimalsCell Line, TumorCell ProliferationColorectal NeoplasmsGene Expression Regulation, NeoplasticHumansKi-67 AntigenMAP Kinase Signaling SystemMiceNeoplasm TransplantationNeovascularization, PathologicProto-Oncogene Proteins c-mycVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Adaptor Proteins, Signal TransducingGAB2 protein, humanKDR protein, humanKi-67 AntigenMYC protein, humanProto-Oncogene Proteins c-mycVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2VEGFA protein, humanAngiogenesisColorectal cancerGab2VEGF

Identifiers

PMID28420432
PMCPMC5395829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.